G
Go Wakabayashi
Researcher at Keio University
Publications - 228
Citations - 5189
Go Wakabayashi is an academic researcher from Keio University. The author has contributed to research in topics: Transplantation & Hepatectomy. The author has an hindex of 37, co-authored 218 publications receiving 4018 citations.
Papers
More filters
Journal ArticleDOI
Tokyo Guidelines 2018: management strategies for gallbladder drainage in patients with acute cholecystitis (with videos).
Yasuhisa Mori,Takao Itoi,Todd H. Baron,Tadahiro Takada,Steven M. Strasberg,Henry A. Pitt,Tomohiko Ukai,Satoru Shikata,Yoshinori Noguchi,Anthony Yuen Bun Teoh,Myung-Hwan Kim,Horacio J. Asbun,Itaru Endo,Masamichi Yokoe,Fumihiko Miura,Kohji Okamoto,Kenji Suzuki,Akiko Umezawa,Yukio Iwashita,Taizo Hibi,Go Wakabayashi,Ho-Seong Han,Yoo Seok Yoon,In Seok Choi,Tsann Long Hwang,Miin Fu Chen,O. James Garden,Harjit Singh,Kui Hin Liau,Wayne Shih Wei Huang,Dirk J. Gouma,Giulio Belli,Christos Dervenis,Eduardo de Santibañes,Mariano E Giménez,John A. Windsor,Wan Yee Lau,Daniel Cherqui,Palepu Jagannath,Avinash Supe,Keng Hao Liu,Cheng Hsi Su,Daniel J. Deziel,Xiao Ping Chen,Sheung Tat Fan,Chen Guo Ker,Eduard Jonas,Robert Padbury,Shuntaro Mukai,Goro Honda,Atsushi Sugioka,Koji Asai,Ryota Higuchi,Keita Wada,Masahiro Yoshida,Toshihiko Mayumi,Koichi Hirata,Yoshinobu Sumiyama,Kazuo Inui,Masakazu Yamamoto +59 more
TL;DR: It is confirmed that percutaneous transhepatic gallbladder drainage should be considered the first alternative to surgical intervention in surgically high‐risk patients with acute cholecystitis.
Journal ArticleDOI
Tokyo Guidelines 2018 management bundles for acute cholangitis and cholecystitis
Toshihiko Mayumi,Kohji Okamoto,Tadahiro Takada,Steven M. Strasberg,Joseph S. Solomkin,David Schlossberg,Henry A. Pitt,Masahiro Yoshida,Harumi Gomi,Fumihiko Miura,O. James Garden,Seiki Kiriyama,Masamichi Yokoe,Itaru Endo,Horacio J. Asbun,Yukio Iwashita,Taizo Hibi,Akiko Umezawa,Kenji Suzuki,Takao Itoi,Jiro Hata,Ho-Seong Han,Tsann Long Hwang,Christos Dervenis,Koji Asai,Yasuhisa Mori,Wayne Shih Wei Huang,Giulio Belli,Shuntaro Mukai,Palepu Jagannath,Daniel Cherqui,Kazuto Kozaka,Todd H. Baron,Eduardo de Santibañes,Ryota Higuchi,Keita Wada,Dirk J. Gouma,Daniel J. Deziel,Kui Hin Liau,Go Wakabayashi,Robert Padbury,Eduard Jonas,Avinash Supe,Harjit Singh,Toshifumi Gabata,Angus C.W. Chan,Wan Yee Lau,Sheung Tat Fan,Miin Fu Chen,Chen Guo Ker,Yoo Seok Yoon,In Seok Choi,Myung-Hwan Kim,Dong Sup Yoon,Seigo Kitano,Masafumi Inomata,Koichi Hirata,Kazuo Inui,Yoshinobu Sumiyama,Masakazu Yamamoto +59 more
TL;DR: Critical parts of the bundles in TG18 include the diagnostic process, severity assessment, transfer of patients if necessary, and therapeutic approach at each time point should improve the prognosis of acute cholangitis and cholecystitis.
Journal ArticleDOI
What has changed after the Morioka consensus conference 2014 on laparoscopic liver resection
TL;DR: The most important message from the ICCLLR is to protect patients from this new surgical procedure, and the online prospective registry system including items to calculate the difficulty score has been created in Japan after the ICC LLR for the safe development of LLR.
Journal ArticleDOI
Interleukin 1 receptor blockade reduces tumor necrosis factor production, tissue injury, and mortality after hepatic ischemia-reperfusion in the rat
Masaya Shito,Go Wakabayashi,Masakazu Ueda,Motohide Shimazu,Nozomu Shirasugi,Masao Endo,Makio Mukai,Masaki Kitajima +7 more
TL;DR: The data demonstrated that the production of IL-1 and TNF increases in hepatic I-R injury and that pretreatment with IL- 1ra protects the liver from ischemic insult, indicating an important role for IL-2 in I- R injury.
Journal ArticleDOI
Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation.
Minoru Tanabe,Motohide Shimazu,Go Wakabayashi,Ken Hoshino,Shigeyuki Kawachi,Tomohisa Kadomura,Hiroaki Seki,Yasuhide Morikawa,Masaki Kitajima +8 more
TL;DR: The experience has shown the feasibility of controlling rejection and other complications in adult ABO-incompatible liver transplantation under intraportal infusion therapy under intraported infusion therapy.